Literature DB >> 27481947

Executive Summary: Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.

Thomas F Patterson1, George R Thompson2, David W Denning3, Jay A Fishman4, Susan Hadley5, Raoul Herbrecht6, Dimitrios P Kontoyiannis7, Kieren A Marr8, Vicki A Morrison9, M Hong Nguyen10, Brahm H Segal11, William J Steinbach12, David A Stevens13, Thomas J Walsh14, John R Wingard15, Jo-Anne H Young16, John E Bennett17.   

Abstract

It is important to realize that guidelines cannot always account for individual variation among patients. They are not intended to supplant physician judgment with respect to particular patients or special clinical situations. IDSA considers adherence to these guidelines to be voluntary, with the ultimate determination regarding their application to be made by the physician in the light of each patient's individual circumstances. Published by Oxford University Press for the Infectious Diseases Society of America 2016. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Keywords:  allergic aspergillosis; amphotericin; aspergillosis; azoles; chronic aspergillosis; echniocandins; fungal diagnostics; invasive aspergillosis

Mesh:

Substances:

Year:  2016        PMID: 27481947      PMCID: PMC4967611          DOI: 10.1093/cid/ciw444

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  81 in total

1.  Inducible Cell Fusion Permits Use of Competitive Fitness Profiling in the Human Pathogenic Fungus Aspergillus fumigatus.

Authors:  Darel Macdonald; Darren D Thomson; Anna Johns; Adriana Contreras Valenzuela; Jane M Gilsenan; Kathryn M Lord; Paul Bowyer; David W Denning; Nick D Read; Michael J Bromley
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

2.  First-in-Human Phase 1 Study To Assess Safety, Tolerability, and Pharmacokinetics of a Novel Antifungal Drug, VL-2397, in Healthy Adults.

Authors:  Mammen P Mammen; Danielle Armas; Frank H Hughes; Andrew M Hopkins; Cindy L Fisher; Pamela A Resch; Denis Rusalov; Sean M Sullivan; Larry R Smith
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

3.  Chronic pulmonary aspergillosis after pulmonary tuberculosis.

Authors:  Edgar Ortiz-Brizuela; Alfredo Ponce-de-León
Journal:  CMAJ       Date:  2018-10-01       Impact factor: 8.262

4.  Diagnostic Value of Galactomannan Antigen Test in Serum and Bronchoalveolar Lavage Fluid Samples from Patients with Nonneutropenic Invasive Pulmonary Aspergillosis.

Authors:  Wei Zhou; Hongxing Li; Yan Zhang; Mei Huang; Qian He; Pei Li; Fang Zhang; Yi Shi; Xin Su
Journal:  J Clin Microbiol       Date:  2017-04-26       Impact factor: 5.948

5.  Pharmacodynamics of Posaconazole in Experimental Invasive Pulmonary Aspergillosis: Utility of Serum Galactomannan as a Dynamic Endpoint of Antifungal Efficacy.

Authors:  Silke Gastine; William Hope; Georg Hempel; Ruta Petraitiene; Vidmantas Petraitis; Diana Mickiene; John Bacher; Thomas J Walsh; Andreas H Groll
Journal:  Antimicrob Agents Chemother       Date:  2021-01-20       Impact factor: 5.191

6.  Early-Onset Invasive Infection Due to Corynespora cassiicola Associated with Compound Heterozygous CARD9 Mutations in a Colombian Patient.

Authors:  Carlos A Arango-Franco; Marcela Moncada-Vélez; Claudia Patricia Beltrán; Indira Berrío; Cristian Mogollón; Andrea Restrepo; Mónica Trujillo; Sara Daniela Osorio; Lorena Castro; Lina Vanessa Gómez; Ana María Muñoz; Verónica Molina; Delsy Yurledy Del Río Cobaleda; Ana Cristina Ruiz; Carlos Garcés; Juan Fernando Alzate; Felipe Cabarcas; Julio Cesar Orrego; Jean-Laurent Casanova; Jacinta Bustamante; Anne Puel; Andrés Augusto Arias; José Luis Franco
Journal:  J Clin Immunol       Date:  2018-09-28       Impact factor: 8.317

7.  Atti Le giornate della ricerca scientificae delle esperienze professionali dei giovani: Società Italiana di Igiene, Medicina Preventiva e Sanità Pubblica (SItI) Roma 20-21 dicembre 2019.

Authors: 
Journal:  J Prev Med Hyg       Date:  2020-02-13

8.  Sniffing out the hypoxia volatile metabolic signature of Aspergillus fumigatus.

Authors:  Christiaan A Rees; Pierre-Hugues Stefanuto; Sarah R Beattie; Katherine M Bultman; Robert A Cramer; Jane E Hill
Journal:  J Breath Res       Date:  2017-08-21       Impact factor: 3.262

Review 9.  Antifungal Susceptibility Testing: Current Approaches.

Authors:  Elizabeth L Berkow; Shawn R Lockhart; Luis Ostrosky-Zeichner
Journal:  Clin Microbiol Rev       Date:  2020-04-29       Impact factor: 26.132

Review 10.  Molecular Tools for the Detection and Deduction of Azole Antifungal Drug Resistance Phenotypes in Aspergillus Species.

Authors:  Anna Dudakova; Birgit Spiess; Marut Tangwattanachuleeporn; Christoph Sasse; Dieter Buchheidt; Michael Weig; Uwe Groß; Oliver Bader
Journal:  Clin Microbiol Rev       Date:  2017-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.